Invox Pharma Limited

Michael Dyson

Francisca Wollerton

Matthew Lakins

Mateusz Wydro

The present disclosure, in some aspects, provides antibody molecules, or antigen-binding fragments thereof capable of binding specifically to PD-L1. The present disclosure further provides antibody molecules, or antigen-binding fragments thereof capable of binding specifically to PD-L1 and a second antigen-binding site. Methods of making and/or using such antibody molecules or antigen bending fragments are also provided.

Growing community of inventors

Sawston, United Kingdom

Michael Dyson